Medication-Responsive Neuromodulation Therapy Coordination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medical treatments for movement disorders, such as Parkinson's Disease, often rely on a combination of medication and neuromodulation therapy, but fail to account for the varying pharmacodynamics and pharmacokinetics of medications, leading to suboptimal treatment efficacy and unwanted side effects.
Innovation Solution
A processing system is used to determine neural tissue activation by medication and adjust stimulation parameters in response to medication levels, allowing for coordinated medication and neuromodulation therapy to optimize treatment outcomes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If medication dosage is increased to improve symptom management, then treatment efficacy is improved, but side effects increase
Solution Approach 1:
The patent combines medication therapy with neuromodulation therapy into a coordinated treatment system. The processing system integrates both therapies and adjusts them together based on their combined effect on neural tissue, allowing the patient to benefit from both treatments while reducing the side effects associated with high medication doses alone
Solution Approach 2:
The system dynamically changes stimulation parameters based on medication levels and their pharmacokinetics. By adjusting stimulation intensity, frequency, or duration in response to medication concentration changes, the system optimizes treatment efficacy while minimizing side effects through parameter adaptation rather than fixed high-dose medication
2Measurement precision
If stimulation parameters are adjusted to account for medication levels, then treatment precision is improved, but system complexity increases
Solution Approach 1:
The processing system implements feedback by continuously monitoring medication levels and their pharmacokinetics, then using this information to automatically adjust stimulation parameters. This closed-loop control improves treatment precision without requiring complex manual intervention, as the system self-regulates based on real-time physiological data
Solution Approach 2:
The system performs self-adjustment of stimulation parameters based on integrated analysis of medication data and neural tissue response models. The processing system autonomously determines optimal parameter settings without requiring constant clinician programming, reducing the operational complexity despite the sophisticated coordination logic
3Reliability
If coordinated therapy adjustment is implemented, then symptom management is improved, but programming complexity increases
Solution Approach 1:
The processing system autonomously coordinates medication and stimulation adjustments based on integrated data analysis. It automatically determines when and how to adjust either therapy modality, eliminating the need for complex manual programming by clinicians and simplifying operation while maintaining sophisticated coordinated control
Data Source
AI summary
Systems and methods for coordination of medication adjustment for neuromodulation therapy are disclosed. An exemplary system comprises a processing system. The processing system may receive medication data associated with administration of medication from a patient in an absence of administering electrostimulation to the patient. The processing system may receive stimulation data associated with administration of electrostimulation therapy to the patient while the patient is not being administered medication. The processing system may compare the medication data to the stimulation data to provide a comparison. The processing system may generate a medication schedule and an electrostimulation schedule based on the comparison to increase efficacy of therapy and minimize side effects.